Suchergebnisse - "Gadelha, Mônica"

PubPharm (23)

1

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

enthalten in: International journal of molecular sciences | 2023

von Henriques, D. | Miranda, R. | Dezonne, R. | +7

2

Routine Evaluation of Somatostatin Receptor Type 2 in Patients With Acromegaly : Do We Still Need More Evidence?

enthalten in: The Journal of clinical endocrinology and metabolism | 2022

von Gatto, F. | Wildemberg, L. | Ferone, D. | +1

CommentOn: J Clin Endocrinol Metab. 2022 Nov 23;107(11):2982-2991. - PMID 36136828

3

MicroRNA in Acromegaly : Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands

enthalten in: International journal of molecular sciences | 2022

von Henriques, D. | Lamback, E. | Dezonne, R. | +2

4

The Future of Somatostatin Receptor Ligands in Acromegaly

enthalten in: The Journal of clinical endocrinology and metabolism | 2022

von Gadelha, M. | Wildemberg, L. | Kasuki, L.

5

GH and IGF-I levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly : a comparative study between two reference centers for pituitary diseases in Brazil

enthalten in: Endocrine | 2021

von Manosso, K. | Sampaio, C. | Kasuki, L. | +3

6

Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor Ligands

enthalten in: The Journal of clinical endocrinology and metabolism | 2021

von Wildemberg, L. | da Silva Camacho, A. | Miranda, R. | +23

7

A Pituitary Society update to acromegaly management guidelines

enthalten in: Pituitary | 2021

von Fleseriu, M. | Biller, B. | Freda, P. | +8

8

Brazilian multicenter study on pegvisomant treatment in acromegaly

enthalten in: Archives of endocrinology and metabolism | 2019

von Boguszewski, C. | Huayllas, M. | Vilar, L. | +12

CommentIn: Arch Endocrinol Metab. 2019 Aug 22;63(4):318-319. - PMID 31460621

9

Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles

enthalten in: Scientific reports | 2019

von Coelho, M. | Vasquez, M. | Wildemberg, L. | +11

10

Treatment escape reduces the effectiveness of cabergoline during long-term treatment of acromegaly in monotherapy or in association with first-generation somatostatin receptor ligands

enthalten in: Clinical endocrinology | 2018

von Kasuki, L. | Dalmolin, M. | Wildemberg, L. | +1